Anti-inflammatory therapy with canakinumab for atherosclerotic disease: Lessons from the CANTOS trial

Peter L. Thompson, S. Mark Nidorf

Research output: Contribution to journal › Editorial › peer-review

36 Citations (Scopus)

Original language	English
Pages (from-to)	695-698
Number of pages	4
Journal	Journal of Thoracic Disease
Volume	10
Issue number	2
DOIs	https://doi.org/10.21037/jtd.2018.01.119
Publication status	Published - 1 Feb 2018

Access to Document

10.21037/jtd.2018.01.119

Other files and links

Link to publication in Scopus

Cite this

@article{0b86f6a5790b49feb50a5dc77b8833a5,

title = "Anti-inflammatory therapy with canakinumab for atherosclerotic disease: Lessons from the CANTOS trial",

author = "Thompson, {Peter L.} and {Mark Nidorf}, S.",

year = "2018",

month = feb,

day = "1",

doi = "10.21037/jtd.2018.01.119",

language = "English",

volume = "10",

pages = "695--698",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

publisher = "AME Publishing Company",

number = "2",

}

TY - JOUR

T1 - Anti-inflammatory therapy with canakinumab for atherosclerotic disease

T2 - Lessons from the CANTOS trial

AU - Thompson, Peter L.

AU - Mark Nidorf, S.

PY - 2018/2/1

Y1 - 2018/2/1

UR - http://www.scopus.com/inward/record.url?scp=85042127293&partnerID=8YFLogxK

U2 - 10.21037/jtd.2018.01.119

DO - 10.21037/jtd.2018.01.119

M3 - Editorial

AN - SCOPUS:85042127293

SN - 2072-1439

VL - 10

SP - 695

EP - 698

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

IS - 2

ER -